GENERATE BIOMEDICINES INCORPORATED (GENB)
Track the next or latest earnings date for GENERATE BIOMEDICINES INCORPORATED, review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
markets.financialcontent.com · 2026-07-31T18:30:52
Hedge funds are using it to beat earnings. You’ve probably never heard of it. This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
Stocks Build on Rally, Led by Tech, Amazon | Charles Schwabwww.schwab.com · 2026-07-31T13:50:03
After a strong rebound Thursday, stocks are poised to finish the week strong. Amazon and Apple are showing mixed results after earnings.
MYGN Looks 64.7% Undervalued on GF Value™ but Faces Price-to-Sales Challengesgurufocus.com · 2026-07-30T21:29:51
On July 30, 2026, Myriad Genetics Inc (MYGN) revised its fiscal 2026 outlook, lowering revenue projections and adjusting its expected gross margin to between 66
Societe Generale tops Q2 profit estimates, raises FY profitability target By Investing.cominvesting.com · 2026-07-30T06:51:21
Societe Generale tops Q2 profit estimates, raises FY profitability target
Stocks bounce back from Fed selloff, Nasdaq snaps 6-day losing streakwww.cnbc.com · 2026-07-29T22:05:25
Investors were digesting megacap tech earnings and the Federal Reserve's decision to hold rates steady.
Upcoming earnings date
Time not specified
Fiscal quarter: 2026-06-30
EPS estimate: -$0.48
Revenue estimate: N/A
Market cap: $1.80B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Aug 06, 2026 | 2026-06-30 | Time not specified | -$0.48 | N/A |